
Bristol-Myers Squibb
Get Full AccessDescription
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. Its products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma Opdivo for anti-cancer indications Eliquis, an oral inhibitor indicated for the reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE and Orencia for adult patients with active RA and psoriatic arthritis, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. The company also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia Yervoy for the treatment of patients with unresectable or metastatic melanoma Abraxane, a solvent-free protein-bound chemotherapy product mpliciti for the treatment of multiple myeloma and Reblozyl for the treatment of anemia in adult patients with beta thalassemia. In addition, it offers Onureg for the continued treatment of adult patients with AML Zeposia to treat relapsing forms of multiple sclerosis Vidaza for the treatment of myelodysplastic syndrome subtypes Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B and Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma. The company sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. It has collaboration agreements with Pfizer, Inc. Otsuka Pharmaceutical Co., Ltd. Ono Pharmaceutical Co., Ltd. Nektar Therapeutics AVEO Pharmaceuticals, Inc. Huyabio and DarwinHealth, Inc. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.
-
Headquarters:345 Park Ave , New York, New York, United States
More -
Phone Number: +1 212-546-4000
-
Website: http://www.bms.com/
-
Employees:32449
-
Revenue:> $1B
-
Legal Name:Bristol-Myers Squibb
-
Bristol-Myers Squibb's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
NYSE: BMY
Show More
Frequently Asked Questions regarding Bristol-Myers Squibb
-
Where are Bristol-Myers Squibb's Headquarters?
Bristol-Myers Squibb's Headquarters are in 345 Park Ave ,New York,New York,United States
-
What is Bristol-Myers Squibb's phone number?
Bristol-Myers Squibb's phone number is +1 212-546-4000
-
What is Bristol-Myers Squibb's stock symbol?
Bristol-Myers Squibb's stock symbol is BMY
-
What is Bristol-Myers Squibb's official website?
Bristol-Myers Squibb's official website is http://www.bms.com/
-
What is Bristol-Myers Squibb's Revenue?
Bristol-Myers Squibb's revenue is > $1B
-
What is Bristol-Myers Squibb's NAICS code?
Bristol-Myers Squibb's NAICS code is 325412
-
How many employees are working in Bristol-Myers Squibb
Bristol-Myers Squibb has 32449 employees
-
What is Bristol-Myers Squibb's Industry?
Bristol-Myers Squibb is in the industry of Pharmaceuticals